Control of the adrenocortical cell cycle: Interaction between FGF2 and ACTH

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 7, 1999, Pages 841-843

  Armelin, H A ^a   Lotfi, C F P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

ACTH; Adrenocortical cell cycle; c fos proto oncogene; ERK MAPK; FCF2

Indexed keywords

CORTICOTROPIN; FIBROBLAST GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN C FOS;

ADRENAL CORTEX TUMOR; ANIMAL; ARTICLE; CELL TRANSFORMATION; DRUG EFFECT; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; FIBROBLAST GROWTH FACTORS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; PROTO-ONCOGENE PROTEINS C-FOS;

EID: 0033158741     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1999000700007     Document Type: Article

References (15)

1. Simpson ER & Waterman MR (1988). Regulation of the synthesis of steroidogenic enzymes in adrenal-cortical cells by ACTH. Annual Review of Physiology, 50: 427-440.
2. Miller WL (1995). Mitochondrial specificity of the early steps in steroidogenesis. Journal of Steroid Biochemistry and Molecular Biology, 55: 607-616.
3. Parker KL & Schimmer BP (1997). Steroidogenic factor 1: a key determinant of endocrine development and function. Endocrine Reviews, 18: 361-377.
4. Stocco DM (1998). A review of the characteristics of the protein required for the acute regulation of steroid hormone biosynthesis: the case for the steroidogenic acute regulatory (StAR) protein. Proceedings of the Society for Experimental Biology and Medicine, 217: 123-129.
5. Kimura E & Armelin HA (1988). c-Fos induction accompanies cell cycle block by ACTH. Journal of Cellular Biochemistry, 12 (Suppl): 220 (Abstract).
6. Kimura E & Armelin HA (1990). Phorbol ester mimics ACTH action in corticoadrenal cells stimulating steroidogenesis, blocking cell cycle, changing cell shape and inducing c-fos proto-oncogene expression. Journal of Biological Chemistry, 265: 3518-3521.
7. Schimmer BP (1981). The adrenocortical tumor cell line, Y-1. In: Sato G (Editor), Functionally Differentiated Cell Lines. Liss, New York, 61-92.
8. Armelin MCS, Gambarini AG & Armelin HA (1977). On the regulation of DNA synthesis in a line of adrenocortical tumor cells: effect of serum, ACTH and pituitary factors. Journal of Cellular Physiology, 93: 1-9.
9. Armelin HA, Lotfi CFP & Lepique AP (1996). Regulation of growth by ACTH in the Y-1 line of mouse adrenocortical cells. Endocrine Research, 22: 373-383.
10. Lotfi CFP, Todorovic Z, Armelin HA & Schimmer BP (1997). Unmasking a growth-promoting effect of adrenocorticotropic hormone in Y1 mouse adrenocortical tumor cell. Journal of Biological Chemistry, 272: 29886-29891.
11. Lotfi CFP & Armelin HA (1998). c-Fos protein is a mediator in mitogenic response to ACTH. Endocrine Research, 24: 421-424.
12. Lazar DF, Wiese RJ, Brady MJ, Mastick CC, Waters SB, Yamauchi K, Pessin JE, Cuatrecasas P & Saltiel AR (1995). MAPK kinase inhibition does not block the stimulation of glucose utilization by insulin. Journal of Biological Chemistry, 270: 20801-20807.
13. Campbel JS, Seger R, Graves JD, Graves LM, Jensen AM & Krebs EG (1995). The MAP kinase cascade. Recent Progress in Hormone Research, 50: 131-159.
14. Rocha KM (1994). Isolamento de clones revertentes normals a partir de celulas Balb/3T3 transformadas com o oncogene humano EJ-ras. Ph.D. thesis, Instituto de Química, Universidade de São Paulo, São Paulo, SP.
15. Lallermand D, Spyson G, Yaniv M & Pfarr CM (1997). Variations in Jun and Fos protein expression and AP1 activity in cycling, resting and stimulated fibroblasts. Oncogene, 14: 819-830.